ADRB2 was closely related to a variety of diseases, such as ADRB2 signaling by inhibiting HIF1 α Autophagy degradation to promote HCC progression and sorafenib resistance (32). The gene discussed is ADRB2; the disease is hepatocellular carcinoma.